Dr. Steven Zygmont, MD (he/him) is an Endocrinologist in East syracuse, NY with over 17 years of experience. What is your opinion of Dr. Steven Zygmont, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Steven Zygmont, MD has received over $594,800 which includes payments from the following companies:
$237,324.72 from AstraZeneca Pharmaceuticals LP
$207,082.38 from Novo Nordisk Inc
$59,436.49 from sanofi-aventis U.S. LLC
$43,820.42 from Boehringer Ingelheim Pharmaceuticals, Inc.
$31,412.89 from Merck Sharp & Dohme Corporation
$13,620.30 from LILLY USA, LLC
$337.50 from Medtronic MiniMed, Inc.
$263.43 from INSULET CORPORATION
$262.15 from Abbott Laboratories
$257.15 from Tandem Diabetes Care, Inc.
$206.79 from Radius Health, Inc.
$151.81 from Takeda Pharmaceuticals America, Inc.
$107.38 from Janssen Pharmaceuticals, Inc
$95.74 from GENZYME CORPORATION
$53.09 from Amarin Pharma Inc.
$48.17 from Otsuka America Pharmaceutical, Inc.
$43.82 from Pfizer Inc.
$37.02 from Eisai Inc.
$33.19 from Alexion Pharmaceuticals, Inc.
$32.34 from Corcept Therapeutics
Payments received by Dr. Steven Zygmont, MD were from the following categories:
$535,500.50 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!